New approach for inhibiting REV function and HIV-1 production using the influenza virus NS1 protein

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 17, 1996, Pages 8873-8877

  Qian, Xiao Yan ^a,d   Chen, Zhong Ying ^a   Zhang, Jianbo ^b,c   Rabson, Arnold B ^b,c   Krug, Robert M ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; MESSENGER RNA; MUTANT PROTEIN; PROTEIN INHIBITOR; REV PROTEIN; RNA BINDING PROTEIN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS A; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RNA BINDING; RNA TRANSPORT; VIRUS INHIBITION;

ANTIVIRAL AGENTS; BIOLOGICAL TRANSPORT; GENE PRODUCTS, REV; HIV-1; MUTATION; RECOMBINANT FUSION PROTEINS; TRANSFECTION; VIRAL NONSTRUCTURAL PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN INFLUENZA VIRUS; INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0029786523     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.17.8873     Document Type: Article

References (26)

1. Malim, M. H., Hauber, J., Le., S. Y., Maizel, J. V. & Cullen, B. R. (1989) Nature (London) 338, 254-257.
2. Felber, B. K., Hadzopoulou-Cladaras, M., Cladaras, C., Copeland, T. & Pavlakis, G. N. (1989) Proc. Natl. Acad. Sci. USA 86, 1495-1499.
3. Hadzopoulou-Cladaras, M., Felber, B. K., Cladaras, C., Athanassopoulos, A., Tse, A. & Pavlakis, G. N. (1989) J. Virol. 63, 1265-1274.
4. Baltimore, D. (1988) Nature (London) 335, 395-396.
5. Malim, M. H., Böhnlein, S., Hauber, J. & Cullen, B. R. (1989) Cell 58, 205-214.
6. Mermer, B., Felber, B. K., Campbell, M. & Pavlakis, G. N. (1990) Nucleic Acids Res. 18, 2037-2044.
7. Bevec, D., Dobrovnik, M., Hauber, J. & Böhnlein, E. (1992) Proc. Nail. Acad. Sci. USA 89, 9870-9874.
8. Malim, M. H., Freimuth, W. W., Liu, J., Boyle, T. J., Lyerly, H. K., Cullen, B. R. & Nabel, G. J. (1992) J. Exp. Med. 176, 1197-1201.
9. Olsen, H. S., Cochrane, A. W., Dillon, P. J., Nalim, C. M. & Rosen, C. A. (1990) Genes Dev. 4, 1357-1364.
10. Zapp, M. L., Hope, T. J., Parslow, T. G. & Green, M. R. (1991) Proc. Natl. Acad. Sci. USA 88, 7734-7738.
11. Malim, M. H. & Cullen, B. R. (1991) Cell 65, 241-248.
12. Hope, T. J., Klein, N. P., Elder, M. E. & Parslow, T. G. (1992) J. Virol. 66, 1849-1855.
13. Bogerd, H. & Greene, W. C. (1993) J. Virol. 67, 2496-2502.
14. Madore, S. J., Tiley, L. S., Malim, M. H. & Cullen, B. R. (1994) Virology 202, 186-194.
15. Alonso-Caplen, F. V., Nemeroff, M. E., Qiu, Y. & Krug, R. M. (1992) Genes Dev. 6, 255-267.
16. Fortes, P., Beloso, A. & Ortin, J. (1994) EMBO J. 13, 704-712.
17. Qiu, Y. & Krug, R. M. (1994) J. Virol. 68, 2425-2432.
18. Qian, X.-Y., Alonso-Caplen, F. V. & Krug, R. M. (1994) J. Virol 68, 2433-2441.
19. Lu, Y., Qian, X.-Y. & Krug, R. M. (1994) Genes Dev. 8, 1817-1828.
20. Qiu, Y., Nemeroff, M. & Krug, R. M. (1995) RNA 1, 304-316.
21. Lu, Y., Wambach, M., Katze, M. G. & Krug, R. M. (1995) Virology 214, 222-228.
22. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A. & Martin, M. A. (1986) J. Virol. 59, 284-291.
23. Willey, R. L., Smith, D. H., Lasky, L. A., Theodore, T. S., Earl, P. L., Moss, B., Capon, D. J. & Martin, M. A. (1988) J. Virol. 63, 139-147.
24. ?4 Leonard, J., Parrott, C., Buckler-White, A. J., Turner, W., Ross, E. J., Martin, M. A. & Rabson, A. B. (1991) J. Virol. 63, 4919-4924.
25. Dimitrov, D. S., Willey, R. L., Sato, H., Chang, L. J., Blumenthal, R. & Martin, M. A. (1993) J. Virol. 67, 2182-2190.
26. Bridges, S. H. & Sarver, N. (1995) Lancet 345, 427-432.